πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 140 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8592389

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586317

Methods of diagnosing hypophosphatemic disorders

Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik Β· Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8455435

Remedies for ischemia

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue Jun 04 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 30 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8425492

In vivo device, system and usage thereof

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8277798

Use of cells containing a specific DNA molecule as cytopathic agents to inhibit the prolif

Bayerische Julius-Maximilians-UniversitΓ€t WΓΌrzburg Β· Granted Tue Oct 02 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8236777

MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Aug 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8207133

Peptides that down regulate the activity of plasma membrane transporters including sodium-

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8207116

Remedies for ischemia

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue Jun 26 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8187605

Means for the inhibition of anti-Ξ²1-adrenergic receptor antibodies

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8173673

Biofilm-inhibiting effect and anti-infective activity of N,C-linked aryl isoquinolines and

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue May 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7947810

Kits for diagnosing a hypophosphatemic disorder

Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik Β· Granted Tue May 24 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7928057

Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeu

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Apr 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7815921

Cytocapacity test for the prediction of the hematopoietic recovery, neutropenic fever, and

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue Oct 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7786080

Mutein of a bone morphogenetic protein and use thereof

Julius-Maximilians-Universitat Wurzburg Β· Granted Tue Aug 31 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745406

Fibroblast growth factor (FGF23) polypeptides

Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik Β· Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563920

Methods for preparing 2-methoxyisobutylisonitrile and tetrakis(2-methoxyisobutylisonitrile

Draximage Limited Β· Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314956

Multifunctional carrier for the delivery of a pharmacological agent or genetic material in

Vaxim, Inc. Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314618

Antibodies to fibroblast growth factor (FGF23)

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223563

Fibroblast growth factor (FGF23) nucleic acids

Ludwig-Maximilians-Universitat Munchen Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6969602

Production of an immunovariant strain of Eimeria maxima contributes to strain cross-protec

The United States of America, as represented by the Secretary of the Agriculture Β· Granted Tue Nov 29 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6893633

Methods and compositions for promoting the maturation of monocytes

Maxim Pharmaceuticals, Inc. Β· Granted Tue May 17 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6821510

Methods and compositions for promoting the maturation of monocytes

Maxim Pharmaceuticals, Inc. Β· Granted Tue Nov 23 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6809191

GM-CSF nucleic acid sequences

Vaxim, Inc. Β· Granted Tue Oct 26 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6790440

Methods and compositions for promoting the maturation of monocytes

Maxim Pharmaceuticals, Inc. Β· Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired